Sales up 10.1%, organic growth of 9.6% Recurring EBITDA margin up, at 21.4% of sales Consolidated financial statements* (in thousands of euros) H1 2024 % of sales H1 2023 % of sales H1 2022 % of sales Change (H1 2024 vs H1 2023) Sales 414,579 100% 376,438 100% 358,865 100% +10.1% Recurring EBITDA 88,919 21.4% 73,576 19.5% 71,611 20.0% +20.9% Recurring operating income 72,808 17.6% 60,966 16.2% 59,386 16.5% +19.4% Net income attributable to owners of the Company 51,688 12.5% 39,935 10.6% 45,061...